上海近岸科技novoprotein
上海近岸科技有限公司(原欣百諾生物)成立于2004年,是國內首家專門從事重組蛋白質制備工藝開發及生產的高科技企業。novoprotein 隸屬于上海近岸科技有限公司,提供重組蛋白制備相關的全套技術服務,包括:基因合成、表達載體構建、發酵、純化、質量檢測、活性檢測及后期加工處理;我們也生產高品質細胞因子、生物活性酶等重組蛋白質相關的試劑產品。
novoprotein 目前成熟的表達體系包括大腸桿菌、酵母、昆蟲細胞和哺乳動物細胞表達系統,每種表達系統都具有克級以上的制備能力。novoprotein 建立了嚴格的產品質控體系及一整套完善的客戶服務流程、保密制度以確保為客戶提供優質的產品及一流的服務。
基于公司出色的重組蛋白質制備平臺,novoprotein 研發生產的細胞因子、酶試劑產品憑借其優良的品質、高性價比贏得了海外細胞因子及生物試劑銷售商的認可,目前我們已與海外十幾家細胞因子與生物試劑銷售企業建立了合作關系。
八年來,我們已完成了千余種重組蛋白質的制備,并開發、制備了40多種分子生物學酶和600余種細胞因子。因為專注所以更專業,我們正在
努力打造重組蛋白質制備領域內的旗艦企業。
SinoBio Biotech (Shanghai) was established in 2004 as an industrial biotechnology initiative from Fudan University. SinoBio understands that protein purification projects are labor intensive, time consuming and riddled with unpredictable outcomes. SinoBio addresses this need for efficient purification services by assembling a team of seasoned biochemists and implementing a streamlined workflow using proprietary chromatographic technologies. The result is SinoBio's highly efficient and scalable pipeline process of recombinant protein purification and production.
Track Record
In four years of commercial operation with 20 scientists, SinoBio has purified nearly 500 recombinant proteins, mg to gram scale, becoming the foremost provider of recombinant protein services to Eastern Asia. SinoBio is also a preferred bulk supplier of 50 enzymes and cytokines to US and European biotechnology reagent vendors. Five drug-related proteins are currently in preclinical trials and one protein is the basis of an IND filing. Scientists in SinoBio Biotech have taken part in 9 major protein drug process development projects, representing one third of biologics in the China protein drug market.